donepezil has been researched along with valacyclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bhatt, H; Borisa, A; Faldu, K; Patel, P; Shah, J | 1 |
1 review(s) available for donepezil and valacyclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for donepezil and valacyclovir
| Article | Year |
|---|---|
Insights of Valacyclovir in Treatment of Alzheimer's Disease: Computational Docking Studies and Scopolamine Rat Model.
Topics: Acetylcholinesterase; Acyclovir; Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antiviral Agents; Butyrylcholinesterase; Donepezil; Humans; Prodrugs; Rats; Scopolamine; Valacyclovir | 2022 |